Acutaas Chemicals Ltd (IN:ACUTAAS)
:ACUTAAS
Want to see IN:ACUTAAS full AI Analyst Report?
ACUTAAS Stock Chart & Stats
₹1747.20
-₹131.70(-5.63%)
At close: 4:00 PM EST
₹1747.20
-₹131.70(-5.63%)
Day’s Range― - ―
52-Week Range₹1,059.05 - ₹3,179.95
Previous CloseN/A
VolumeN/A
Average Volume (3M)14.81K
Market Cap
₹256.88B
Enterprise Value₹254.57B
Total Cash (Recent Filing)₹2.80B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)72.0
Beta1.30
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.09%
Share Statistics
EPS (TTM)27.88
Shares Outstanding81,871,124
10 Day Avg. Volume15,850
30 Day Avg. Volume14,806
Financial Highlights & Ratios
PEG Ratio0.49
Price to Book (P/B)12.67
Price to Sales (P/S)15.64
P/FCF Ratio-733.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)55.87
Revenue Forecast (FY)₹17.28B
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue And MarginsFY2026's ~52% revenue jump alongside net margin ~26.6% and EBIT margin ~33.2% indicates durable operating leverage and improved mix. Such structural improvement supports sustained cash generation potential and competitive strength if the company maintains execution and market demand.
Very Low Recent LeverageA conservatively positioned balance sheet with debt-to-equity near 0.01–0.02 gives the company financial flexibility for capex, product investment, or cyclical shocks. Low leverage reduces refinancing risk and supports strategic optionality over the medium term.
Improved Operating Cash ConversionOperating cash flow materially improved in FY2026 and covered reported earnings (~1.3x), signaling better cash generation from core operations. If sustained, this strengthens internal funding for growth and reduces reliance on external financing over the next several quarters.
Bears Say
Persistent Negative Free Cash FlowConsistent negative free cash flow (≈-0.29B in FY2026) reflects heavy reinvestment or working-capital drains and limits excess cash for dividends, buybacks, or rapid deleveraging. Over months, this constrains balance-sheet optionality if operating cash conversion weakens.
Cash-flow VolatilityHistorical swings in operating cash (including a negative OCF year) increase forecasting risk and weaken confidence that recent improvements will persist. Volatile cash conversion raises the chance of funding gaps in downturns and complicates capital allocation decisions.
Earnings And Margin InconsistencyWide margin dispersion (net margin ~6.0% in FY2024 vs ~26.6% in FY2026) shows earnings are sensitive to mix, pricing or cost cycles. Such inconsistency reduces predictability of profitability and increases execution risk for sustaining current high margins over time.
Acutaas Chemicals News
ACUTAAS FAQ
What was Acutaas Chemicals Ltd’s price range in the past 12 months?
Acutaas Chemicals Ltd lowest stock price was ₹1059.05 and its highest was ₹3179.95 in the past 12 months.
What is Acutaas Chemicals Ltd’s market cap?
Acutaas Chemicals Ltd’s market cap is ₹256.88B.
When is Acutaas Chemicals Ltd’s upcoming earnings report date?
Acutaas Chemicals Ltd’s upcoming earnings report date is Aug 06, 2026 which is in 66 days.
How were Acutaas Chemicals Ltd’s earnings last quarter?
Acutaas Chemicals Ltd released its earnings results on Apr 30, 2026. The company reported ₹16.1 earnings per share for the quarter, beating the consensus estimate of ₹13.05 by ₹3.05.
Is Acutaas Chemicals Ltd overvalued?
According to Wall Street analysts Acutaas Chemicals Ltd’s price is currently Overvalued.
Does Acutaas Chemicals Ltd pay dividends?
Acutaas Chemicals Ltd pays a Annually dividend of ₹1.5 which represents an annual dividend yield of 0.09%. See more information on Acutaas Chemicals Ltd dividends here
What is Acutaas Chemicals Ltd’s EPS estimate?
Acutaas Chemicals Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acutaas Chemicals Ltd have?
Acutaas Chemicals Ltd has 81,871,124 shares outstanding.
What happened to Acutaas Chemicals Ltd’s price movement after its last earnings report?
Acutaas Chemicals Ltd reported an EPS of ₹16.1 in its last earnings report, beating expectations of ₹13.05. Following the earnings report the stock price went up 3.841%.
Which hedge fund is a major shareholder of Acutaas Chemicals Ltd?
Currently, no hedge funds are holding shares in IN:ACUTAAS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Acutaas Chemicals Ltd
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist chemicals to semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals. The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limited was founded in 2004 and is based in Surat, India.
Technical Analysis
Alkyl Amines Chemicals Limited
―
Anupam Rasayan India Ltd.
―
Balaji Amines Limited
―
HEG Limited
―
Rallis India Limited
―